Literature DB >> 15472992

Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1.

David P Crockett1, Mark Burshteyn, Corina Garcia, Michela Muggironi, Patrizia Casaccia-Bonnefil.   

Abstract

Remyelination is a critical step for recovery of function after demyelination and defines the ability to generate new myelin. This repair process is dependent on the presence of resident oligodendrocyte progenitors (OLPs) that have been shown to remyelinate axons after demyelination. We have previously shown that the levels of the cell cycle inhibitor p27Kip-1 modulate the number of neonatal cortical OLPs. We now asked whether this cell cycle molecule plays also a role in regulating the number of adult OLP in the spinal cord after demyelination induced by lysolecithin injection. The proliferative response of OLP in the spinal cord of injected wild-type (wt) and p27Kip-1 null mice was evaluated 3 days after lesion. In vivo labeling with bromodeoxyuridine (BrdU) was used to identify cells in S phase. Double immunofluorescence for the OLP marker NG2, and for BrdU was used to count the number of proliferating progenitors. Consistent with a role of p27Kip-1 in regulating the number of adult OLP in the injured spinal cord, a larger number of proliferating OLPs was observed in p27Kip-1null mice compared with wild-type controls. These cells were able to differentiate as assessed by the presence of MBP+ cells in the spinal cord 14 days after injury. We conclude that the cellular levels of the cell cycle inhibitor p27Kip-1 modulate the repair response of OLPs to injury in the adult spinal cord.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15472992     DOI: 10.1002/glia.20111

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  16 in total

1.  Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.

Authors:  Chun-Xiao Yuan; Takho Chu; Li Liu; Hao-Wen Li; Ya-Jie Wang; An-Chen Guo; Yong-Ping Fan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 2.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 3.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

Review 4.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

Review 5.  Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

Authors:  Reshmi Tognatta; Robert H Miller
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

Review 6.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

7.  Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation.

Authors:  Weizhen Ye; Georges Mairet-Coello; Elise Pasoreck; Emanuel Dicicco-Bloom
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

8.  Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-mediated p27Kip1 expression.

Authors:  Beata Jablonska; Joseph Scafidi; Adan Aguirre; Flora Vaccarino; Vien Nguyen; Erzsebet Borok; Tamas L Horvath; David H Rowitch; Vittorio Gallo
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

Review 9.  Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.

Authors:  Jane M Rodgers; Andrew P Robinson; Stephen D Miller
Journal:  Discov Med       Date:  2013-08       Impact factor: 2.970

10.  The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury.

Authors:  Christian Maier; Angelika Scheuerle; Balázs Hauser; Hubert Schelzig; Csaba Szabó; Peter Radermacher; Jochen Kick
Journal:  Intensive Care Med       Date:  2007-03-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.